Fetalix
A regenerative, fetal-inspired solution for treating low back pain through a minimally invasive approach. Learn more
Launch date
Employees
Porto Porto (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
€10.0k | Support Program | ||
€7.0k | Support Program | ||
€75.0k | Support Program | ||
Total Funding | €92.0k |
Recent News about Fetalix
EditMore about Fetalix
EditWe provide the first regenerative fetal-inspired solution to treat low back pain through a minimally-invasive application.
Our developed and patented natural biomaterial is obtained from a mammalian fetal source offering unique regenerative properties.
This injectable and off-the-shelf material provides veterinaries and orthopaedic surgeons a new and preventive treatment for intervertebral disc degeneration, eliminating the need for surgical procedures and reoperations, while reducing intervention time by 90% and hospital stays by 70%.
Production is simple, safe, affordable and scalable and promotes circular economy by creating value from animal waste.